EU Transdermal Patch: Generic Submission [Design Issues]

posted by HallaGulla – 2023-03-08 09:58 (386 d 09:48 ago) – Posting: # 23491
Views: 955

(edited by on 2023-03-08 11:11)

Hi All

One of the clients with whom I am working is developing a generic transdermal patch for UK/EU submission.

They are asking us to do the PK study, Adhesion study and skin senstization study in either EU/UK or in USA due to simialr climatic condition.

My question is, can these studies be done in India or any other countries? Does MHRA/EMA accepts transdermal studies done in the geographies which has a different climatic conditions?


TIA...


Edit: Category changed; see also this post #1. Are you really located in Japan? ;-) [Helmut]

:lol: Shhhhh

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
81 visitors (0 registered, 81 guests [including 7 identified bots]).
Forum time: 19:47 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5